189 related articles for article (PubMed ID: 20401641)
1. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).
Yang Y; Zhu J; Gou H; Cao D; Jiang M; Hou M
Med Oncol; 2011 Sep; 28(3):796-803. PubMed ID: 20401641
[TBL] [Abstract][Full Text] [Related]
2. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
3. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival.
Kapiris I; Nastos K; Karakatsanis A; Theodosopoulos T; Karandrea D; Kondi Pafiti A; Contis J
J BUON; 2019; 24(5):1934-1942. PubMed ID: 31786858
[TBL] [Abstract][Full Text] [Related]
5. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.
Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y
BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709
[TBL] [Abstract][Full Text] [Related]
6. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.
Kong J; Zhou X; Liu S; Jin T; Piao Y; Liu C; Lin Z
Int J Clin Exp Pathol; 2014; 7(6):3018-27. PubMed ID: 25031720
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma.
Song K; Gao Q; Zhou J; Qiu SJ; Huang XW; Wang XY; Fan J
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):177-84. PubMed ID: 22484587
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
11. The expression of Survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma.
Jin Y; Chen J; Feng Z; Fan W; Wang Y; Li J; Tong D
Tumour Biol; 2014 Oct; 35(10):9905-10. PubMed ID: 24996542
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
13. Correlations of MRI manifestations with survivin gene expression in primary hepatic carcinoma.
Li J; Ma R; Cao Z; Zhang D
Cancer Biomark; 2018; 23(1):45-51. PubMed ID: 30010107
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
[TBL] [Abstract][Full Text] [Related]
16. Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma.
Ye CP; Qiu CZ; Huang ZX; Su QC; Zhuang W; Wu RL; Li XF
World J Gastroenterol; 2007 Dec; 13(46):6264-8. PubMed ID: 18069771
[TBL] [Abstract][Full Text] [Related]
17. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
18. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
19. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
20. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]